Skip to main content

Table 2 Medication at admission

From: Gender differences in patients presenting with non-ST segment elevation myocardial infarction in the STAR registry

Medications 24 h Male Female Total P value
Aspirin 592 (99.00%) 163 (99.39%) 755 (99.08%) 0.640
Clopidogrel 533 (89.13%) 154 (93.90%) 687 (90.16%) 0.069
Prasugrel 3 (0.50%) 0 (0.00%) 3 (0.39%) 0.363
Ticagrelor 59 (9.87%) 5 (3.05%) 64 (8.40%) 0.005
Beta blockers 531 (88.80%) 130 (79.27%) 661 (86.75%) 0.001
ACEI/ARB 462 (77.26%) 132 (80.49%) 594 (77.95%) 0.377
Statins 570 (95.32%) 159 (96.95%) 729 (95.67%) 0.363
Aldosterone inhibitor (spironolactone) 54 (9.03%) 18 (10.98%) 72 (9.45%) 0.451
Heparins UH/LMWH 552 (92.31%) 148 (90.24%) 700 (91.86%) 0.392
GP_2b3a_inhibitors 97 (16.22%) 15 (9.15%) 112 (14.70%) 0.023
Insulin 284 (47.49%) 114 (69.51%) 398 (52.23%) < .001
Oral hp agents 74 (12.37%) 32 (19.51%) 106 (13.91%) 0.019